Product News

Seegene's product news

Obtained CE-IVD marking for Allplex™ Meningitis Panel Assays

Meningitis Pathogen Allplex™ Meningitis Panel Assays 2018.05.09

Seegene has received CE-IVD mark under European Union on In Vitro Diagnostics Medical Devices for Allplex™ Meningitis Panel-V1, Allplex™ Meningitis-V2 Assay, Allplex™ Meningitis-B Assay.

These assays are the multiplex one-step Real-time RT-PCR assay that detect and identifie 18 meningitis causative pathogens including 12 viruses and 6 bacteria. Based on Seegene’s proprietary MuDT™ technology, it allows reporting of each Ct value for multiple pathogens in a single channel without the melt curve analysis.

Previous Next List
Previous Obtained approval of MFDS for Allplex™ GI- Bacteria(I) Assay 2017.05.26
Next Obtained CE-IVD marking for Allplex™ GI-Virus plus Assay 2019.01.22
home > News > Product news